Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, used to treat several types of blood cancers, as well as a serious complication of allogeneic stem cell tra···【more】
Article source：Captain MedicineRelease date：2026-03-12Recommended：123
What are the common adverse reactions to Gilteritinib fumarate?Common reactions include: abnormal liver function (elevated ALT/AST), anemia, decreased platelets, febrile neutropeni···【more】
Article source：Captain MedicineRelease date：2026-03-11Recommended：151
What drugs does Gilteritinib Fumarate Tablets interact with?Before taking this medication, you must inform your doctor of all medications you are currently using and any health pro···【more】
Article source：Captain MedicineRelease date：2026-03-11Recommended：135
Use of Gilteritinib Fumarate Tablets with Other MedicationsDuring treatment, doctors may combine Gilteritinib Fumarate Tablets with other leukemia treatments (such as chemotherapy ···【more】
Article source：Captain MedicineRelease date：2026-03-11Recommended：145
Indications and EfficacyThe main component of Gilteritinib Fumarate Tablets is gilteritinib fumarate, which is an anti-tumor medication.This medication should be used under the gui···【more】
Article source：Captain MedicineRelease date：2026-03-11Recommended：133
During treatment with Selumetinib, in addition to its expected therapeutic effects, this medication may cause some adverse effects. While not all side effects occur, some may requi···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：242
August 1, 2017 -- The U.S. Food and Drug Administration today approved Enasidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who h···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：148
During treatment with Enasidenib, in addition to the expected therapeutic effects, some adverse effects may also occur. While not all side effects happen, some may require medical ···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：199
On November 29, 2018, the U.S. Food and Drug Administration (FDA) warned that symptoms of differentiation syndrome, a life-threatening side effect associated with the leukemia drug···【more】
Article source：Captain MedicineRelease date：2026-03-10Recommended：173
Entrectinib is a targeted anticancer drug primarily used to treat solid tumors and lymphomas carrying specific gene mutations. Common side effects include fatigue, dizziness, and c···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：192
The price of entrectinib fluctuates due to differences in specifications, purchasing channels, and regions. The price of the original brand-name drug may be higher, while some gene···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：154
The price of entrectinib varies depending on factors such as region, medical insurance policies, dosage specifications, and purchasing channels. The specific monthly treatment cost···【more】
Article source：Captain MedicineRelease date：2026-03-09Recommended：165
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended：[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended：[list:visits]2026-21-07
Company Overview: Industrial Migration from India to LaosLucius Pharmaceuticals (Laos) Co., Ltd. was···【more】
Recommended：[list:visits]2026-20-07
Lucius Pharmaceutical is one of the representative generic drug enterprises in Laos. The company was···【more】
Recommended：[list:visits]2026-17-07
Industrial Rise: From Zero to a "World Pharmacy" CandidateThe explosive growth of Laos'···【more】
Recommended：[list:visits]2026-16-07
In recent years, Laos generic drugs have gradually come into view of oncology and chronic disease pa···【more】
Recommended：[list:visits]2026-15-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
